Diagnostic and prognostic role of the SARS-COV-2-specific IgA antibody: an updated systematic review and meta-analysis

Main Article Content

Hamda Shazam
Yasir Butt


OBJECTIVE: This systematic review and meta-analysis aimed to investigate the diagnostic accuracy and prognostic role of the SARS-CoV-2-specific IgA antibody.

METHODS:  A computerized search was conducted on MEDLINE, Scopus, Web of Science, Cochrane Library, and Google Scholar, using the relative keywords. Received citations were screened, and relevant data were extracted from the included studies. The methodological quality of the articles was assessed through modified version of the quality assessment of diagnostic accuracy studies tool-2. To analyze the risk of bias, four domains were reviewed: patient selection, index test, reference standard and flow & timing; three domains, patient selection, index test, and reference standard, were assessed based on applicability. Review Manager-5.4 and Meta-DiSc were used for analysis.

RESULTS: Twenty-nine studies were included in the qualitative synthesis, and only 15 studies were included in the quantitative synthesis. On pooled analysis, the overall sensitivity of IgA was 90% (87% to 92%), specificity 94% (92% to 95%), positive likelihood ratio (LR) 9.33 (3.40 to 25.57), negative LR 0.14 (0.05 to 0.37), diagnostic Odds Ratio 71.5 (13.22 to 382.80), and overall area under the curve was 96.5%. Overall random effect estimate demonstrated a significant elevation of IgA in the severe group [standardized mean difference=0.23, 95% CI 0.10 to 0.36), p=0.0005], compared to non-severe group.

CONCLUSION: The current evidence suggests that IgA has good sensitivity, specificity, and accuracy in detecting patients with COVID-19 along with the clinical and laboratory characteristics. The prognostic role of IgA needs more comprehensive investigations on larger samples to reach conclusive evidence.

Article Details

How to Cite
Shazam, H., and Y. Butt. “Diagnostic and Prognostic Role of the SARS-COV-2-Specific IgA Antibody: An Updated Systematic Review and Meta-Analysis”. KHYBER MEDICAL UNIVERSITY JOURNAL, vol. 15, no. 2, June 2023, pp. 122-33, doi:10.35845/kmuj.2023.22498.
Systematic Review & Meta-Analysis


Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol [Internet]. 2021 Mar 6;19(3):141–54. [Accessed on: Dec 03, 2021]. Available from URL: https://www.nature.com/articles/s41579-020-00459-7

Emery SL, Erdman DD, Bowen MD, Newton BR, Winchell JM, Meyer RF, et al. Real-Time Reverse Transcription–Polymerase Chain Reaction Assay for SARS-associated Coronavirus. Emerg Infect Dis [Internet]. 2004 Feb;10(2):311–6. [Accessed on: Dec 03, 2021]. Available from URL: http://wwwnc.cdc.gov/eid/article/10/2/03-0759_article.htm

Kanji JN, Zelyas N, MacDonald C, Pabbaraju K, Khan MN, Prasad A, et al. False negative rate of COVID-19 PCR testing: a discordant testing analysis. Virol J [Internet]. 2021 Dec 9;18(1):13. [Accessed on: Dec 03, 2021]. Available from URL: https://virologyj.biomedcentral.com/articles/10.1186/s12985-021-01489-0

De Pace V, Caligiuri P, Ricucci V, Nigro N, Galano B, Visconti V, et al. Rapid diagnosis of SARS-CoV-2 pneumonia on lower respiratory tract specimens. BMC Infect Dis [Internet]. 2021 Dec 8;21(1):926. [Accessed on: Dec 03, 2021]. Available from URL: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06591-w

Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA [Internet]. 2020 Jun 9;323(22):2249. [Accessed on: Dec 03, 2021]. Available from URL: https://jamanetwork.com/journals/jama/fullarticle/2765837

Nakano Y, Kurano M, Morita Y, Shimura T, Yokoyama R, Qian C, et al. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan. Sci Rep [Internet]. 2021 Feb 2;11(1):2776. [Accessed on: Dec 03, 2021]. Available from URL: https://www.nature.com/articles/s41598-021-82428-5

Lisboa Bastos M, Tavaziva G, Abidi SK, Campbell JR, Haraoui LP, Johnston JC, et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ [Internet]. 2020 Jul 1;m2516. [Accessed on: Dec 04, 2021]. Available from URL: https://www.bmj.com/lookup/doi/10.1136/bmj.m2516

Wuthiekanun V, Amornchai P, Chierakul W, Cheng AC, White NJ, Peacock SJ, et al. Evaluation of Immunoglobulin M (IgM) and IgG Rapid Cassette Test Kits for Diagnosis of Melioidosis in an Area of Endemicity. J Clin Microbiol [Internet]. 2004 Aug;42(8):3435–7. [Accessed on: Dec 03, 2021]. Available from URL: https://journals.asm.org/doi/10.1128/JCM.42.8.3435-3437.2004

Chao YX, Rötzschke O, Tan EK. The role of IgA in COVID-19. Brain Behav Immun [Internet]. 2020 Jul;87:182–3. [Accessed on: Dec 03, 2021]. Available from URL: https://linkinghub.elsevier.com/retrieve/pii/S0889159120310473

Zervou FN, Louie P, Stachel A, Zacharioudakis IM, Ortiz‐Mendez Y, Thomas K, et al. SARS‐CoV‐2 antibodies: IgA correlates with severity of disease in early COVID‐19 infection. J Med Virol [Internet]. 2021 Sep 12;93(9):5409–15. [Accessed on: Dec 03, 2021]. Available from URL: https://onlinelibrary.wiley.com/doi/10.1002/jmv.27058

Caselli E, Soffritti I, Lamberti G, D’Accolti M, Franco F, Demaria D, et al. Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients. Biology (Basel). 2020 Nov;9(11).

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med [Internet]. 2009 Jul 21;6(7):e1000097. [Accessed on: Dec 04, 2021]. Available from URL: https://dx.plos.org/10.1371/journal.pmed.1000097

Whiting PF. QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies. Ann Intern Med [Internet]. 2011 Oct 18;155(8):529. [Accessed on: Dec 04, 2021]. Available from URL: http://annals.org/article.aspx?doi=10.7326/0003-4819-155-8-201110180-00009

Reinwald M, Deckert PM, Ritter O, Andresen H, Schreyer AG, Weylandt KH, et al. Prevalence and Course of IgA and IgG Antibodies against SARS-CoV-2 in Healthcare Workers during the First Wave of the COVID-19 Outbreak in Germany: Interim Results from an Ongoing Observational Cohort Study. Healthc (Basel, Switzerland). 2021 Apr;9(5).

Xue M, Zhang T, Hu H, Huang Z, Zhen Y, Liang Y, et al. Predictive effects of IgA and IgG combination to assess pulmonary exudation progression in COVID-19 patients. J Med Virol. 2021 Mar;93(3):1443–8.

Staats LAN, Pfeiffer H, Knopf J, Lindemann A, Fürst J, Kremer AE, et al. IgA2 antibodies against SARS-CoV-2 correlate with NET formation and fatal outcome in severely diseased COVID-19 patients. Cells. 2020 Dec;9(12).

Aita A, Basso D, Cattelan AM, Fioretto P, Navaglia F, Barbaro F, et al. SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis. Clin Chim Acta. 2020 Nov;510:717–22.

Carnicelli A, Fiori B, Ricci R, Piano A, Bonadia N, Taddei E, et al. Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital. Intern Emerg Med. 2022 Jan;17(1):53–64.

Caramelli B, Escalante-Rojas MC, Chauhan HKC, Siciliano RF, Bittencourt MS, Micelli AC. The “false-positive” conundrum: IgA reference level overestimates the seroprevalence of antibodies to SARS-CoV-2. J Glob Health. 2021 Jan;11:5001.

Fox A, Marino J, Amanat F, Krammer F, Hahn-Holbrook J, Zolla-Pazner S, et al. Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk. iScience. 2020 Nov;23(11):101735.

Ali OH, Bomze D, Risch L, Brugger SD, Paprotny M, Weber M, et al. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis [Internet]. 2021 Nov 2;73(9):e2869–74. [Accessed on: Dec 03, 2021]. Available from URL: https://academic.oup.com/cid/article/73/9/e2869/5913451

Infantino M, Manfredi M, Grossi V, Lari B, Fabbri S, Benucci M, et al. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies. J Med Virol. 2021 Mar;93(3):1436–42.

Ivanov A, Semenova E. Long-term monitoring of the development and extinction of IgA and IgG responses to SARS-CoV-2 infection. J Med Virol. 2021 Oct;93(10):5953–60.

Juncker HG, Romijn M, Loth VN, Ruhé EJM, Bakker S, Kleinendorst S, et al. Antibodies against SARS-CoV-2 in human milk: milk conversion rates in the Netherlands. J Hum Lact Off J Int Lact Consult Assoc. 2021 Aug;37(3):469–76.

Needle R, Gilbert L, Zahariadis G, Yu Y, Dalton-Kenny H, Russell RS, et al. Serological Evaluation of human antibodies of the immunoglobulin class A and G against SARS-CoV-2 in serum collected in Newfoundland and Labrador. Viral Immunol. 2021 Apr;34(3):182–9.

Cao M, Zhang D, Wang Y, Lu Y, Zhu X, Li Y, et al. Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China. medRxiv : the preprint server for health sciences. United States; 2020.

Chen M, Qin R, Jiang M, Yang Z, Wen W, Li J. Clinical applications of detecting IgG, IgM or IgA antibody for the diagnosis of COVID-19: A meta-analysis and systematic review. Int J Infect Dis [Internet]. 2021 Mar;104:415–22. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1201971221000266

Fu Y, Pan Y, Li Z, Li Y. The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis. Front Microbiol [Internet]. 2021 Jan 13;11. [Accessed on: Dec 03, 2021]. Available from URL: https://www.frontiersin.org/articles/10.3389/fmicb.2020.603058/full

He Z, Ren L, Yang J, Guo L, Feng L, Ma C, et al. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. Lancet (London, England). 2021 Mar;397(10279):1075–84.

Han Y, Zhang H, Mu S, Wei W, Jin C, Tong C, et al. Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study. Aging (Albany NY). 2020 Jun;12(12):11245–58.

Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine [Internet]. 2020 May;55:102763. [Accessed on: Dec 03, 2021]. Available from URL: https://linkinghub.elsevier.com/retrieve/pii/S2352396420301389

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis [Internet]. 2020 Jul 28;71(15):762–8. [Accessed on: Dec 03, 2021]. Available from URL: https://academic.oup.com/cid/article/71/15/762/5803306

Beavis KG, Matushek SM, Abeleda APF, Bethel C, Hunt C, Gillen S, et al. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2020 Aug;129:104468.

Brandstetter S, Roth S, Harner S, Buntrock-Döpke H, Toncheva AA, Borchers N, et al. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak. Pediatr allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2020 Oct;31(7):841–7.

Jääskeläinen AJ, Kekäläinen E, Kallio-Kokko H, Mannonen L, Kortela E, Vapalahti O, et al. Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples. Eurosurveillance [Internet]. 2020 May 7;25(18). [Accessed on: Dec 03, 2021]. Available from URL: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.18.2000603

Lassaunière R, Frische A, Harboe ZB, Nielsen ACY, Fomsgaard A, Krogfelt KA, et al. Evaluation of nine commercial SARS-CoV-2 immunoassays. medRxiv [Internet]. 2020 Jan 1;2020.04.09.20056325. [Accessed on: Dec 03, 2021]. Available from URL: http://medrxiv.org/content/early/2020/04/10/2020.04.09.20056325.abstract

Montesinos I, Gruson D, Kabamba B, Dahma H, Van den Wijngaert S, Reza S, et al. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J Clin Virol [Internet]. 2020 Jul;128:104413. [Accessed on: Dec 03, 2021]. Available from URL: https://linkinghub.elsevier.com/retrieve/pii/S1386653220301554

Çölkesen F, Kepenek Kurt E, Vatansev H, Korkmaz C, Çölkesen F, Yücel F, et al. Memory B cells and serum immunoglobulins are associated with disease severity and mortality in patients with COVID-19. Postgrad Med J. 2022 Oct;98(1164):765–71.

Ma H, Zeng W, He H, Zhao D, Jiang D, Zhou P, et al. Serum IgA, IgM, and IgG responses in COVID-19. Cell Mol Immunol. 2020 Jul;17(7):773–5.

Nie J, Li Q, Wu J, Zhao C, Hao H, Liu H, et al. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat Protoc. 2020 Nov;15(11):3699–715.

Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med [Internet]. 2020 Apr 3;46(4):586–90. [Accessed on: Dec 05, 2021]. Available from URL: http://link.springer.com/10.1007/s00134-020-05985-9

Yang J, Petitjean SJL, Koehler M, Zhang Q, Dumitru AC, Chen W, et al. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun [Internet]. 2020 Sep 11;11(1):4541. [Accessed on: Dec 05, 2021]. Available from URL: https://www.nature.com/articles/s41467-020-18319-6

Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick LC, Rattigan SM, et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat Commun [Internet]. 2020 Sep 17;11(1):4704. [Accessed on: Dec 05, 2021]. Available from URL: https://www.nature.com/articles/s41467-020-18450-4

Klumpp-Thomas C, Kalish H, Drew M, Hunsberger S, Snead K, Fay MP, et al. Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling. Nat Commun [Internet]. 2021 Jan 4;12(1):113. [Accessed on: Dec 05, 2021]. Available from URL: https://www.nature.com/articles/s41467-020-20383-x

Varadhachary A, Chatterjee D, Garza J, Garr RP, Foley C, Letkeman AF, et al. Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19. medRxiv : the preprint server for health sciences. United States; 2020.

Fu YQ, Sun YL, Lu SW, Yang Y, Wang Y, Xu F. Effect of blood analysis and immune function on the prognosis of patients with COVID-19. Tan W, editor. PLoS One [Internet]. 2020 Oct 30;15(10):e0240751. [Accessed on: Dec 05, 2021]. Available from URL: https://dx.plos.org/10.1371/journal.pone.0240751

Liu K, Yang T, Peng X, Lv S, Ye X, Zhao T, et al. A systematic meta‐analysis of immune signatures in patients with COVID‐19. Rev Med Virol [Internet]. 2021 Jul 20;31(4). [Accessed on: Dec 03, 2021]. Available from URL: https://onlinelibrary.wiley.com/doi/10.1002/r mv.2195